Scholars Central

ArticlePublished 2009

Selective RNAi-mediated inhibition of mutated c-kit

Authors: Irene Ruano, Marta Izquierdo

Journal of RNA and Genomics

Volume 7 · Issue 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The proto-oncogene c-kit plays an important role in the development and survival of mast cells. Gain-offunction mutations in c-kit are one of the most characteristic events in mast cell leukemia (MCL) but as yet there is no clinically approved treatment for the disease. Here we describe growth inhibition of human MCL cell lines by the use of RNAi against c-kit or its mutant form. Retroviral transduction of HMC1.1 and HMC1.2 cell lines with vectors carrying DNA to be transcribed to RNAi against the wild type or mutant c-kit messengers reduced Kit protein levels considerably, decreased cell proliferation, and increased the apoptotic levels five days after retroviral infection. Thus RNAi targeted against Kit or its mutant form could be considered as a new antiproliferative agent against human mast leukemia cell lines, especially HMC1.2 cells which are resistant to the Kit tyrosine kinase inhibitor, imatinib mesylate.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of RNA and Genomics
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Irene Ruano”
  • BylineArticles whose byline prints “Marta Izquierdo”